NEWS
![]() Qureight Secures $20M Series B to Expand AI Imaging Platform for Clinical TrialsThe company aims to develop new AI disease models for lung and heart conditions, enhancing imaging analytics and cost efficiency in clinical research. This is a news summary compiled for the AiPulse newsletter — not the original article. The original article is at tech.eu. Read the original article AI Critique → English (automatic translation) |
